MARATTO

article · The International Journal of Health Planning and Management

Adopting telemedicine in the fight against antimicrobial resistance in West Africa

20241 citationUniversity of Ibadan

Abstract

The detrimental effects of antimicrobial resistance (AMR) have called for several approaches in the fight against it in West Africa, where telemedicine is still in its infancy. In West Africa, self-medication is prevalent because the majority of these medications are easily accessible due to insufficient regulatory structures that control their production, distribution, and consumption. Also, access to healthcare facilities and professionals is limited. All of these and other inadequacies consequently result in the emergence of antimicrobial-resistant organisms. AMR, which is now a major global health crisis according to the WHO, may cause the deaths of about 10 million people before 2050, and Africa may make up 41% of these deaths, with the Western part of this continent affected the most. While several approaches have been adopted, unlike in other regions of the world, the use of telemedicine in West Africa to fight AMR has rarely been studied or considered and where it is now in partial use, its efficacy is constrained by several factors. This paper discusses the roles of telemedicine, the limitations to its application in the fight against AMR, and suggests remedies for these limitations.

Research topics

  • Telemedicine and Telehealth Implementation
  • Mobile Health and mHealth Applications
  • COVID-19 epidemiological studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/hpm.3799

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.